2-Pyrrolidone → HCID 71252958, compound
Reaction equation
[NH:1]1[CH2:5][CH2:4][CH2:3][C:2]1=[O:6].Br[C:8]1[N:13]=[CH:12][C:11]([C:14]([N:16]2[CH2:21][CH2:20][N:19]([C:22]3[C:27]([CH3:28])=[CH:26][C:25]([CH2:29][CH3:30])=[CH:24][N:23]=3)[CH2:18][CH2:17]2)=[O:15])=[CH:10][CH:9]=1>>[CH2:29]([C:25]1[CH:26]=[C:27]([CH3:28])[C:22]([N:19]2[CH2:20][CH2:21][N:16]([C:14]([C:11]3[CH:10]=[CH:9][C:8]([N:1]4[CH2:5][CH2:4][CH2:3][C:2]4=[O:6])=[N:13][CH:12]=3)=[O:15])[CH2:17][CH2:18]2)=[N:23][CH:24]=1)[CH3:30]Participants
3
Procedure
Using pyrrolidin-2-one (49 mg) and (6-bromopyridin-3-yl)[4-(5-ethyl-3-methylpyridin-2-yl)piperazin-1-yl]methanone (200 mg) described in Preparation Example 145 and by the reaction and treatment in the same manner as in Example 1, the title compound (113 mg) was obtained.
Workup
- customdescribed in Preparation Example 145 and by the reaction and treatment in the same manner as in Example 1
Sources & evidence
- ORD record
- ord-16821c6e55a644b4a3d9acf1d51b83fe
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…